Sector

Healthcare & Medical

Live opportunities

749

Largest live: £105.1bn

A high-activity UK & EU sector, led by NHS ENGLAND, most recent listing today.

United Kingdom + 5 moreAvg value £23.5m+53% · 30 days

Clinical services, medical equipment, pharmaceuticals, NHS contracts, and health research.

Live opportunities

749

Largest live: £105.1bn

Activity, last 12 months

7K published

2025-09Peak: 2026-06 · 1K2026-09

Sector brief

4 fields

Live now
749
Opportunities open today
Total on record
12K
Across all statuses
Total value (£ only)
£281.7bn
Avg £23.5m
30-day momentum
+53%
Last published -1 days ago

Opportunities

700 on record

Germany

Non-Exclusive Discount Agreement for Umeclidinium

The DAK-Gesundheit is seeking pharmaceutical companies to enter into a non-exclusive discount agreement for the drug Umeclidinium (ATC R03BB07) under the provisions of § 130a Abs. 8 SGB V. This agreement will be effective from September 1, 2025, to August 31, 2027. The process will follow the formal

€1nominalDAK HEALTH

Published 16 Jul 2025

Germany

Non-Exclusive Discount Agreement for Abrocitinib

The DAK-Gesundheit is seeking suppliers to enter into a non-exclusive discount agreement for the drug Abrocitinib (ATC D11AH08) under the provisions of § 130a Abs. 8 SGB V. This agreement will be effective from September 1, 2025, to August 31, 2027. The process will involve formal procurement proced

€1nominalDAK HEALTH

Published 16 Jul 2025

Germany

Non-Exclusive Discount Agreement for Tafluprost + Timolol

The DAK-Gesundheit is seeking suppliers to enter into a non-exclusive discount agreement for the medication containing the active ingredients Tafluprost and Timolol (ATC S01ED70). This agreement is in accordance with § 130a Abs. 8 SGB V, which allows health insurance companies and pharmaceutical com

€1nominalDAK HEALTH

Published 16 Jul 2025

Germany

Germany – Medicines – Medicines Containing Tramadol and Paracetamol

This contract opportunity involves the establishment of non-exclusive discount agreements for finished medicines containing the active ingredients Tramadol and Paracetamol (ATC: N02AJ13) under an 'open-house model'. All eligible and interested pharmaceutical companies or consortia are invited to ent

AOK SACHSEN ANHALT

Published 13 Jul 2025

Germany

Open House Discount Contracts for Airpiprazol

AOK Bayern is seeking pharmaceutical companies to enter into non-exclusive discount agreements for the drug Airpiprazol in the form of depot injection suspension (ATC N05AX12). This is not a traditional open procedure but an open-house model, meaning contracts can be signed at any time until July 3,

AOK BAYERN THE HEALTH INSURANCE FUND

Published 13 Jul 2025

Germany

Framework Agreement for Blood Glucose Test Strips in North Rhine-Westphalia

This announcement is for the establishment of agreements with companies or consortia of companies for blood glucose test strips in accordance with Section 130a, Paragraph 8 of the Fifth Book of the Social Code (SGB V) for the state of North Rhine-Westphalia. Suppliers are invited to participate in a

DEUTSCHE PENSION INSURANCE KNAPPSCHAFTBAHNSEE

Published 10 Jul 2025

Germany

Germany – Pharmaceutical Discounts Agreement

The KKH (Kaufmännische Krankenkasse) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under the Open-House procedure as per § 130a Abs. 8 SGB V. This process allows all eligible and interested pharmaceutical companies or groups to

KKH COMMERCIAL HEALTH INSURANCE

Published 10 Jul 2025

Germany

Open House Discount Contracts for Blood Glucose Test Strips in Germany

This is not a standard open procedure but rather an open-house model! The form for the open procedure is used only because there is no form for the open-house model. Contracts made under the open-house model are not subject to procurement law due to the lack of selection decisions. The AOK Bayern in

AOK BAYERN THE HEALTH INSURANCE FUND

Published 10 Jul 2025

Germany

Germany – Supply Contracts for Medical Dressings Starting August 1, 2025

This announcement is for the establishment of contracts to supply medical dressings to the insured members of AOK NW, in accordance with § 31 SGB V, through an Open-House procedure. All qualified and interested service providers are invited to enter into this contract under uniform contractual condi

AOK NORDWEST

Published 19 Jun 2025

Germany

Procurement of Nilotinib Medicines

This contract opportunity involves the establishment of non-exclusive discount agreements for finished medicines containing the active ingredient Nilotinib (ATC: L01EA03) under an 'open-house model'. All eligible and interested pharmaceutical companies or consortia are invited to enter into or join

AOK SACHSEN ANHALT

Published 17 Jun 2025